YSB

9885
3.2502.26% ( -0.075 )
Delay Closed: Nov 16, 16:08:11

Overview

YSB (9885)

YSB Inc. operates a digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in Chin...

Open
3.335
High
3.405
Low
3.065
Prev. Close
3.325
Volume
3.69M
Turnover
11.90M
Avg Price
3.226
Bid/Ask Ratio
36.36%
Amplitude
10.23%
52wk High
7.965
Volume Ratio
3.12
Turnover Ratio
0.53%
52wk Low
2.960
HK Mkt Cap
2.25B
Market CapHKD
2.25B
P/ETTM
10.53
P/EDynamic
8.82
P/EStatic
--
EPSTTM
0.309
EPSDynamic
0.369
EPSStatic
--
BVPS
3.96
P/B
0.82
HK Shares
692.49M
Dividend YieldTTM
3.82%
DividendTTM
0.124
Shares
692.49M
Min lot size
200
Currency
HKD

YSB Analyst Rating

View more

Forecast & Rating

Sep 28, 2025
Price forecast
HK$9.85203.13%
Forecast & RatingStrong buy
1analysts
  • Strong buy100.00%
  • Buy0.00%
  • Hold0.00%
  • Sell0.00%
  • Strong sell0.00%

Daily Events

  1. Jul, 3

    YSB closed up 5.73% at HKD 4.800, driven by the 'supply assurance' sales growth narrative amid the flu season and sustained share buybacks plus executive director share increases. The stock staged a single-session rally from an intraday low of 4.500 to a high of 4.840, finishing near the session peak. Latest quarterly results showed Q4 revenue up 27.96% YoY to HKD 6.19B, net profit surging 854.93% YoY, and EPS expanding 808.18% YoY, reflecting strong margin improvement. While the stock remains 62.09% below its 52-week high of 12.66, it has reclaimed both MA20 (3.598) and MA60 (4.301), signaling a recovery from the earlier trough. However, YTD performance is still down 10.78%, suggesting uneven valuation restoration.

News